Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


timothy.betts@cardiov.ox.ac.uk


+44 (0)1865 220256
Fax +44 (0)1865 221194


Kayleigh Morris
kayleigh.morris@ouh.nhs.uk

Websites

Timothy Betts

MD, MBChB, FRCP

Associate Professor of Cardiovascular Medicine

  • Consultant Cardiologist and Electrophysiologist
  • Clinical Lead for Cardiac Rhythm Management

Cardiac Rhythm Management

Consultant Cardiologist and Clinical Lead for Cardiac Electrophysiology at Oxford University Hospitals NHS Foundation Trust.

Practices in all aspects of cardiac rhythm management including catheter ablation, complex device therapy and left atrial appendage occlusion.

Leads an active commercial research programme with an excellent team of Research Nurses, Data Administrators and Cardiac Physiologists, supported by the Thames Valley CRN. PI of multiple NIHR portfolio studies in AF ablation (STAR-AF2, UNCOVER-AF, RECOVER-AF, DISCOVER-AF,); Heart failure device therapy (CARDIOMEMS-OUS, MORE-MPP CRT, SYNC-AV, LV-Only, SOLVE-CRT, WiSE-CRT registry); leadless pacing (NANOSTIM, AVIER-DR IDE) and left atrial appendage occlusion (EWOLUTION, ASAP-TOO, CHAMPION-AF, ICE-LAAO). 

Leads a number of investigator-led programmes with PhD students that are exploring the role of charge-density global-non-contact mapping to determine the mechanisms, substrate and potential ablation targets for atrial fibrillation (collaboration with Acutus Medical); the innovative approach of "as-required" oral anticoagulation in low-burden atrial fibrillation (the SMART-Alert study, funded by a Heart Research UK New and Emerging Technologies grant), and stereotactic radioablation to treat cardiac arrhythmias (collaboration with GenesisCare).

Recent publications

More publications